Showing results (81-90 of 309) with videos related to
Sort By:
Pageof 31
Thrombosis and Haemostasis|February 3, 1987
Immunological relationship between plasminogen activator inhibitors from different sourcesG Urdén, J Chmielewska, T Carlsson, et al.The Biochemical Journal|January 1, 1990
The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activatorT L Lindahl, P I Ohlsson, B WimanThrombosis Research|August 15, 2006
Low PAI-1 activity in relation to the risk for perioperative bleeding complications in transurethral resection of the prostateA Agren, T Kolmert, B Wiman, et al.Thrombosis Research|September 1, 1985
Thrombolysis and fibrinolytic parameters during heparin treatment of deep vein thrombosisS Schulman, S Granqvist, B Wiman, et al.Thrombosis and Haemostasis|October 31, 1984
The fast inhibitor of tissue plasminogen activator in plasma during pregnancyB Wiman, G Csemiczky, L Marsk, et al.Scandinavian Journal of Clinical and Laboratory Investigation|February 1, 1983
Determination of plasmin-alpha 2-antiplasmin complex in plasma samples by means of a radioimmunoassayB Wiman, L Jacobsson, M Andersson, et al.Acta Anaesthesiologica Scandinavica|February 1, 1993
Laboratory methods for detecting disseminated intravascular coagulation (DIC): new aspectsS Bredbacka, M Blombäck, B Wiman, et al.Journal of the American College of Cardiology|September 1, 1994
Clinical and biochemical factors associated with prognosis after myocardial infarction at a young ageK Malmberg, P Båvenholm, A HamstenAtherosclerosis|May 1, 1990
Abnormalities of composition and of in vitro lipolysis products of human small very low density lipoproteins in hypertriglyceridemiaP Tornvall, A Hamsten, L A CarlsonJournal of Internal Medicine|October 1, 1989
Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acidL A Carlson, A Hamsten, A AsplundPageof 31